|Systematic (IUPAC) name|
|Legal status||Schedule I (CA) Class A (UK) Schedule I (US)|
|Mol. mass||354.461 g/mol|
|(what is this?)|
Para-fluorofentanyl was sold briefly on the black market in the early 1980s, before the introduction of the Federal Analog Act which for the first time attempted to control entire families of drugs based on their structural similarity rather than scheduling each drug individually as they appeared. Para-fluorofentanyl is made with the same synthetic route as fentanyl, but by substituting para-fluoroaniline for aniline in the synthesis.
Para-fluorofentanyl has similar effects to fentanyl but is reported to have a potency slightly stronger than the parent drug. Side effects of fentanyl analogues are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression which can be life-threatening.
- US patent 3164600
- Henderson, G. L. (1988). "Designer Drugs: Past History and Future Prospects". Journal of Forensic Sciences 33 (2): 569–575. PMID 3286815.
- Ulens, C.; Van Boven, M.; Daenens, P.; Tytgat, J. (2000). "Interaction of p-Fluorofentanyl on Cloned Human Opioid Receptors and Exploration of the Role of Trp-318 and His-319 in μ-Opioid Receptor Selectivity" (pdf). The Journal of Pharmacology and Experimental Therapeutics 294 (3): 1024–1033. PMID 10945855.
|This analgesic-related article is a stub. You can help Wikipedia by expanding it.|